AI
HALO icon

Axiom Investors’s Halozyme HALO Stock Holding History

Axiom Investors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-31,715
Closed -$1.21M – 145
2023
Q3 		$1.21M Buy
31,715
+4,660
+17% +$191K 0.02% 114
2023
Q2 		$976K Sell
27,055
-13,705
-34% -$468K 0.01% 119
2023
Q1 		$1.56M Sell
40,760
-71,605
-64% -$3.36M 0.03% 111
2022
Q4 		$6.39M Sell
112,365
-1,060
-0.9% -$54.3K 0.13% 77
2022
Q3 		$4.49M Buy
113,425
+26,500
+30% +$1.17M 0.09% 84
2022
Q2 		$3.83M Buy
86,925
+22,393
+35% +$968K 0.11% 84
2022
Q1 		$2.57M Sell
64,532
-17,914
-22% -$638K 0.06% 99
2021
Q4 		$3.31M Sell
82,446
-13,949
-14% -$521K 0.06% 98
2021
Q3 		$3.92M Sell
96,395
-11,040
-10% -$462K 0.06% 100
2021
Q2 		$4.88M Buy
107,435
+4,605
+4% +$204K 0.08% 87
2021
Q1 		$4.29M Sell
102,830
-27,920
-21% -$1.27M 0.08% 102
2020
Q4 		$5.58M Buy
+130,750
New +$4.7M 0.09% 86

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Axiom Investors's HALO Position: Q4 2023 in Review

Axiom Investors sold out of Halozyme (HALO) in Q4 2023, closing a stake of 31,715 shares — an estimated $1.21M sold.

Axiom Investors first reported a position in HALO in Q4 2020 and held it in 12 quarters. The position peaked at $6.39M in Q4 2022. 410 funds tracked by Wall St. Rank hold HALO as of Q4 2023.

  • Axiom Investors reported no remaining Halozyme position as of Q4 2023 after selling out during the quarter.
  • Axiom Investors sold 31,715 Halozyme shares in Q4 2023, an estimated $1.21M.
  • Axiom Investors first reported a position in Halozyme in Q4 2020 and held it in 12 quarters.
  • Axiom Investors's Halozyme position peaked at $6.39M in Q4 2022.
  • 410 funds tracked by Wall St. Rank held Halozyme as of Q4 2023.

Based on Axiom Investors's 13F filing for Q4 2023, filed 12 Feb 2024.